written on 14.03.2014

US court decision stands in Actelion fasudil damages case


"Actelion is disappointed by the decision and strongly believe there are significant reasons why the Supreme Court should have reviewed the case. The judgment now stands," the Swiss specialty pharma firm said in a statement.

Latest Reports